Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease

We have evaluated the clinical efficacy of the combination of oral rifampin at 10 mg/kg of body weight and intramuscular streptomycin at 15 mg/kg for 8 weeks (RS8), as recommended by the WHO, in 160 PCR-confirmed cases of Mycobacterium ulcerans disease. In 152 patients (95%) with all forms of diseas...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sarfo, Fred Stephen, Phillips, Richard, Asiedu, Kingsley, Ampadu, Edwin, Bobi, Nana, Adentwe, E., Lartey, Awuli, Tetteh, Ishmael, Wansbrough-Jones, M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology (ASM) 2010
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935024/
https://ncbi.nlm.nih.gov/pubmed/20566765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00299-10
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk